Wealthspire Advisors LLC Sells 4,105 Shares of iShares Biotechnology ETF $IBB

Wealthspire Advisors LLC lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 37.2% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,921 shares of the financial services provider’s stock after selling 4,105 shares during the period. Wealthspire Advisors LLC’s holdings in iShares Biotechnology ETF were worth $876,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Citigroup Inc. raised its stake in iShares Biotechnology ETF by 88.5% during the first quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock worth $410,322,000 after acquiring an additional 1,505,976 shares in the last quarter. Millennium Management LLC grew its holdings in shares of iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares during the last quarter. Jones Financial Companies Lllp increased its position in iShares Biotechnology ETF by 763.3% during the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock worth $19,347,000 after purchasing an additional 133,744 shares in the last quarter. Ashton Thomas Private Wealth LLC lifted its stake in iShares Biotechnology ETF by 769.9% in the 2nd quarter. Ashton Thomas Private Wealth LLC now owns 63,691 shares of the financial services provider’s stock valued at $8,058,000 after purchasing an additional 56,369 shares during the last quarter. Finally, Generali Investments CEE investicni spolecnost a.s. boosted its position in iShares Biotechnology ETF by 35.0% in the second quarter. Generali Investments CEE investicni spolecnost a.s. now owns 116,115 shares of the financial services provider’s stock valued at $14,690,000 after buying an additional 30,115 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.6%

Shares of NASDAQ:IBB opened at $164.24 on Friday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $168.50. The company has a fifty day moving average of $152.83 and a 200-day moving average of $138.05.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.